Coverage Exception denied for failing step therapy by Blue Cross Blue Shield?
Step-therapy denials usually flip when the appeal documents that prior alternatives were tried and failed, or were contraindicated, or aren't safe for the patient.
US health-plan appeal rights
Cite: Most US health plans have appeal rights under either the ACA, ERISA, or Medicare/Medicaid rules
Most US health plans are required by federal law to give you both an internal appeal (where the insurer reconsiders) and an external review (where an independent reviewer decides). The exact timelines and processes depend on what kind of plan you have — marketplace / employer group, self-funded, Medicare Advantage, or Medicaid MCO — but in every case there's a window after the denial during which you have the right to fight it.
What Blue Cross Blue Shield typically requires
Blue Cross Blue Shield's specific coverage criteria for coverage exception are defined in its own published medical/coverage policy and the FDA-approved prescribing label. A successful appeal documents that your medical records satisfy each criterion those sources list — confirmed diagnosis, any required prior treatments (with dates and outcomes), and clinical severity. If the exact criteria weren't included with your denial, request them in writing; your appeal then maps each requirement to the matching fact in your chart.
The Blue Cross Blue Shield angle on Coverage Exception
## Why BCBS Denied Your Coverage Exception Under Step Therapy
A step-therapy denial means BCBS requires you to try one or more preferred (typically lower-cost) treatments before it will approve coverage for the treatment your prescriber requested. This "fail-first" approach is a standard cost-management tool, and it frequently catches patients who have already tried and failed the required alternatives — or who have a documented medical reason why those alternatives are contraindicated or unsuitable.
Step-therapy denials are among the most winnable appeals when there is chart documentation of a prior adequate trial of the required step(s), because the entire premise of the denial — that you have not yet tried the required alternative — is factually incorrect.
## Your Federal Appeal Rights
- Internal appeal (ACA §2719 / ERISA §503): You have the right to a full-and-fair internal review. Submit a written appeal within the timeframe on your denial letter — typically 180 days.
- External review: After the final internal decision, you may request independent external review within approximately four months. The IRO decision is binding on the plan.
- State step-therapy protections: Many states have enacted step-therapy reform laws that require insurers to grant exceptions when certain clinical conditions are met (e.g., prior failure, contraindication, clinical equivalence concern). If you are in a fully-insured plan (not ERISA self-funded), check whether your state's step-therapy exception law applies — it may provide additional grounds and a separate exception pathway.
- Expedited review: If delay poses a serious health risk, request expedited internal review (typically 72 hours) and concurrent expedited external review.
## How to Build Your Appeal
1. Document every prior step with dates and outcomes. For each alternative BCBS requires, provide pharmacy records, visit notes, and prescriber documentation showing: when the treatment was tried, at what stage it was used, what happened (adverse event, inadequate response, contraindication observed), and why the prescriber discontinued or avoided it.
2. Obtain the BCBS step-therapy policy. Request the exact policy governing step-therapy requirements for this treatment. Copy each step requirement and exception criterion into your appeal.
3. Build a criterion-by-criterion response. For each step listed in the policy, provide the specific chart evidence showing you have satisfied that step or qualify for an exception.
4. Get a prescriber letter that addresses step completion or exception grounds. The letter should confirm — with chart-based evidence — either that you completed the required steps, or that a recognized clinical reason exempts you from them.
5. Reference applicable clinical guidelines by organization. Where relevant specialty society guidance supports bypassing step therapy in your clinical situation, your prescriber's letter should reference the organization (e.g., applicable ADA, ACC, or NCCN guideline).
## Timeline
- File promptly within the window on your denial notice.
- After a final internal denial, request external review within approximately four months.
DenialHelp can help you map your prior-treatment history against BCBS's step-therapy requirements and build a structured appeal.
Next steps
- Find the date on the denial letter — your appeal window starts there.
- Read your plan's Summary of Benefits and Coverage (SBC) for the specific deadlines.
- Request the insurer's claim file in writing — they must provide it.
- Submit your appeal in writing with new clinical evidence and a physician statement.
Get the letter drafted
DenialHelp drafts your appeal in 5 minutes — $40 list price, $30 for your first letter (use code SEO25). We cite the federal regs and the specific clinical evidence your plan responds to. Your physician signs and sends.
Start my appeal — $30 with code SEO25 →Related appeal guides
- Blue Cross Blue Shield denied for failing step therapy of 17ohp Compounded
- Blue Cross Blue Shield denied for failing step therapy of AAT Augmentation
- Blue Cross Blue Shield denied for failing step therapy of Amphetamine Stimulant Prodrug
- Blue Cross Blue Shield denied for failing step therapy of Anti Cd 20 Ocrevus